A MEMS Based Drug Delivery Device with Integrated Micro-Needle Array - Design and Simulation

Author(s):  
Farshid Meshkinfam ◽  
Ghaus Rizvi

Abstract One of the most effective treatments for type 1 and 2 diabetes is the administration of Insulin. Single needle mechanical insulin pumps are heavy and painful. Micro-needle based MEMS drug delivery devices can be an excellent solution for insulin dosing. The use of Micro-Needle Array provides a safe, painless and robust injection application. A stackable structure results in minimum dimensions and the final product can be in the form of a patch that can be applied to any flat area of human skin. The design of positive volumetric insulin pump is a multi-physics problem where the volumetric changes of the main pump chamber and the pumped fluid are directly coupled. We used a multiphysics simulation platform to investigate the performance of a MEMS based Insulin Micro-Pump driven by a piezoelectric actuator which acts on a diaphragm. The positive and negative movement of the diaphragm results in generation of a discharge pressure at the microneedle array. The pressure and flow rate is controlled by varying the excitation voltage and frequency applied to the actuator. The model was used to evaluate the performance of the Micro-Pump. It was found to be capable of generating the required interfacial pressures at the human skin to deliver the target dosage by matching the minimum and maximum range of diabetic patients' operating parameters.

Diabetes Care ◽  
2011 ◽  
Vol 34 (5) ◽  
pp. 1089-1090 ◽  
Author(s):  
A. Kuroda ◽  
H. Kaneto ◽  
T. Yasuda ◽  
M. Matsuhisa ◽  
K. Miyashita ◽  
...  

2020 ◽  
Vol 23 (4) ◽  
pp. 281
Author(s):  
Foglia , A.

In the lockdown period, during the recent pandemic from COVID-19, the use of telemedicine for all categories of chronic patients has been encouraged by all scientific societies and governing bodies. In type 1 diabetic patients, telemedicine has been used for some time to control and verify the state of metabolic balance, through specific platforms for data download. There are numerous evidences that support the positive effect of insulin therapy by insulin pump (CSII) compared to multinjective insulin therapy and the use of continuous blood glucose monitoring systems (CGM) and integrated insulin pump systems and glycemic monitoring (SAP). The purpose of our study is to describe the results of our first experience of remote implants through the use of telemedicine of insulin pumps and continuous glycemic monitoring in four patients with type 1 diabetes in low metabolic compensation complicated by hypoglycemias. Two weeks after the insulin pump has been implanted, a hypoglycemic episode reset was recorded in all patients and the ‘time in range’ was greater than 90% in three of the four patients. Furthermore, the implanted patients were given a survey to evaluate their experience and everyone declared that they were satisfied overall. Our first and small experience of pump system through the use of remote technologies has obtained encouraging results and could be taken into consideration for the therapeutic management of selected patients, trained in the use of technologies and followed over time. KEY WORDS diabetes mellitus; insulin pumps; telemedicine system.


2006 ◽  
Vol 91 (9) ◽  
pp. 3507-3514 ◽  
Author(s):  
Lucia Puricelli ◽  
Elisabetta Iori ◽  
Renato Millioni ◽  
Giorgio Arrigoni ◽  
Peter James ◽  
...  

Abstract Context: Protein profiling of diabetic tissues could provide useful biomarkers for early diagnosis, therapeutic targets, and disease response markers. Cultured fibroblasts are a useful in vitro model for proteome analysis and study of the molecular mechanisms involved in diabetes. Objective: The objective of the study was to isolate and characterize the proteins of cultured fibroblasts, obtained by skin biopsy, from long-term type 1 diabetic patients without complications and age- and sex-matched normal subjects as controls. Design: Proteins were separated by two-dimensional electrophoresis (2-DE), and the gel images were qualitatively and quantitatively analyzed. Protein identification was performed by matrix-assisted laser desorption/ionization mass spectrometry. Results: Reproducible protein maps of fibroblasts from diabetic and healthy subjects were obtained. A total of 125 protein spots were isolated and identified, among them 27 proteins not previously reported in published human fibroblast 2-DE maps, including 20 proteins never reported previously in the literature in human skin fibroblasts. Quantitative analyses revealed six protein spots differentially expressed in the fibroblasts from the diabetic vs. the control subjects (P < 0.05), representing glycolytic enzymes and structural proteins. An increase of triosephosphate I isomerase of two splice isoforms of pyruvate kinase and α-actinin 4 and a decrease of tubulin-β2 and splice isoform 2 of tropomyosin β-chain were detected. Conclusions: We generated 2-DE reference maps of the proteome of human skin fibroblasts from both normal and uncomplicated type 1 diabetic patients. Differences in glycolytic enzymes and structural proteins were found. The functional implications of the identified proteins are discussed.


1991 ◽  
Vol 69 (17) ◽  
pp. 802-807 ◽  
Author(s):  
A. Hübinger ◽  
K. Wiefels ◽  
D. Ziegler ◽  
F. A. Gries

Sign in / Sign up

Export Citation Format

Share Document